Protecting Kratom Access: Mandating Research and Public FDA Regulation.
This bill aims to protect consumer access to kratom products by preventing the Food and Drug Administration (FDA) from imposing immediate, restrictive regulations. It mandates the government to conduct open scientific research and public hearings on kratom's safety and benefits before any new rules can be implemented. This ensures kratom remains available as a dietary supplement unless clear evidence of contamination or health risks justifies restrictions.
Key points
Access Protection: The FDA is prohibited from imposing stricter requirements on kratom than those applied to standard dietary supplements, maintaining its current availability.
Mandatory Research: A dedicated Task Force will be established to coordinate and publish all federally funded research on kratom, covering potential benefits and addiction risks.
Transparent Regulation: Any future FDA attempts to regulate kratom must follow formal procedures, including public, in-person hearings, ensuring citizen input and transparency.
Expired
Citizen Poll